NBA commissioner Adam Silver on Monday met in Wauwatosa with GE Healthcare U.S. and Canada president and chief executive officer Marcelo Mosci and other NBA and GE Healthcare executives to discuss the research collaboration between the two organizations.
The partnership between the NBA and GE Healthcare, which began in July, promotes sports medicine research. Monday’s session reaffirmed a collective commitment to advance the prevention, diagnosis and treatment of musculoskeletal conditions among NBA players and to extend those findings to the broader population.
“Player health and wellness is our top priority, and the NBA’s research partnership with GE Healthcare is a significant step toward understanding injuries that affect NBA players,” said Silver. “Both every day athletes and elite professionals will benefit from our collaboration, and I’d like to thank Marcelo and his team for their bold vision and hard work.”
The group’s discussions included an overview of the research collaboration, including the announcement of a call for research proposals on tendinopathy. The collaboration will fund up to a total of $1.5 million for researchers over a three-year period to support research addressing important unanswered questions regarding tendinopathy diagnosis, treatment and prevention in elite basketball athletes.
“At GE Healthcare, we are committed to investing in research and applying our know-how in healthcare imaging technology to address the prevention, diagnosis and treatment of musculoskeletal injuries,” said Mosci. “It was a pleasure hosting Adam and his leadership team here in Milwaukee to collaborate and drive discussions on how we can advance innovative methods to address the health and wellness of elite athletes and the general population alike.”
The deadline to submit research proposals is February 10, 2016.
